A comparison between p53 accumulation determined by immunohistochemistry and TP53 mutations as prognostic variables in tumours from breast cancer patients

By Alsner Jan   Jensen Vibeke   Kyndi Marianne   Vrou Offersen Birgitte   Vu Phuong   Børresen-Dale Anne-Lise   Overgaard Jens  

Acta Oncologica, Vol. 47, Iss. 4, 2008-01 ,pp. : 600-607

Informa Healthcare

Access to resources Recommend Favorite

Prevalence of germline TP53 mutations in HER2+ breast cancer patients

By Rath Michelle  

Breast Cancer Research and Treatment, Vol. 139, Iss. 1, 2013-05 ,pp. : 193-198

Springer Publishing Company

Access to resources Recommend Favorite

B-Raf Mutations, Microsatellite Instability and p53 Protein Expression in Sporadic Basal Cell Carcinomas

By Stamatelli Angeliki  

Pathology & Oncology Research, Vol. 17, Iss. 3, 2011-09 ,pp. : 633-637

Springer Publishing Company

Access to resources Recommend Favorite

Significant Difference in p53 and p21 Protein Immunoreactivity in HPV 16 Positive and HPV Negative Breast Carcinomas

By Hennig Elin M.   Kvinnsland Stener   Holm Ruth   Nesland Jahn M.  

Acta Oncologica, Vol. 38, Iss. 7, 1999-11 ,pp. : 931-938

Informa Healthcare

Access to resources Recommend Favorite

p53 Protein Expression, Cell Proliferation and Steroid Hormone Receptors in Ductal and Lobular In Situ Carcinomas of the Breast

By Rudas M.   Neumayer R.   Gnant M.F.X.   Mittelbock M.   Jakesz R.   Reiner A.  

European Journal of Cancer, Vol. 33, Iss. 1, 1997-01 ,pp. : 39-44

Elsevier

Access to resources Recommend Favorite